Infectious complications following CAR-t cell therapy for B cell non-Hodgkin lymphoma: a single-center experience and review of the literature.

Mercadal, Santiago; Gomez, Carlos A; Lee, Catherine J; Couriel, Daniel R

Mercadal, Santiago; Gomez, Carlos A; Lee, Catherine J; Couriel, Daniel R.

Afiliación

Mercadal S; Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA. smercadal@iconcologia.net.
Gomez CA; Bone Marrow Transplant/Cellular Therapy and Regenerative Medicine, University of Utah, 2000 Cir of Hope Dr Ste 1950, Salt Lake City, Utah, 84112, USA. smercadal@iconcologia.net.
Lee CJ; Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Couriel DR; Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

Ann Hematol ; 102(7): 1837-1843, 2023 Jul.

Article en En | MEDLINE | ID: mdl-37246975

Asunto(s)

COVID-19; Linfoma de Células B; Receptores Quiméricos de Antígenos; Humanos; Anciano; Vacunas contra la COVID-19; SARS-CoV-2; Linfoma de Células B/terapia; Tratamiento Basado en Trasplante de Células y Tejidos; Antígenos CD19

Palabras clave

B-cell NHL; CAR-T; Infectious complications

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Células B / Receptores Quiméricos de Antígenos / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google